Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | MTOR | P42345 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.62 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.62 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.62 |
| ▸ | GMNN | O75496 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.62 |
| ▸ | THPO | P40225 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | HBB | P68871 | 1/20 | 0.62 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.62 |
| ▸ | PYGM | P11217 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CDA | P32320 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2583859 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL12937913 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL19657184 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL770113 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL12230437 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL6297249 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1THRBMDM2 | |
| Phosphoric Acid SCHEMBL20240168 | 0.95 | LMNA (0.57) | LMNAMTORALDH1A1THRBMDM2 | |
| Phosphoric Acid SCHEMBL5501341 | 0.95 | LMNA (0.57) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL24826957 | 0.89 | LMNA (0.49) | LMNAMTORALDH1A1THRBMDM2 | |
| Fiacitabine SCHEMBL138934 | 0.89 | PDE2A (0.50) | LMNAMTORALDH1A1THRBMDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2373 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4711452-A2 | KLOTHO MRNA | ADvantage Therapeutics, Inc. (US) | 2026-03-18 | — | — | EP | claimed |
| EP-4676525-A2 | CORONAVIRUS VACCINES | DIOSynVax Ltd (GB) | 2026-01-14 | — | — | EP | claimed |
| US-20250367301-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TRIPLE-NEGATIVE BREAST CANCER, COMPRISING OLIGONUCLEOTIDE AS ACTIVE INGREDIENT | INTEROLIGO CORPORATION (KR) | 2025-12-04 | — | — | US | claimed |
| US-20250340868-A1 | POLYNUCLEOTIDES ENCODING LINKED ANTIGENS AND USES THEREOF | STEMCELL TECHNOLOGIES CANADA INC (CA) | 2025-11-06 | — | — | US | claimed |
| US-12448624-B2 | Modified nucleic acid having improved treatment efficacy, and anticancer pharmaceutical composition containing same | INTEROLIGO CORPORATION (KR) | 2025-10-21 | — | — | US | claimed |
| US-12343420-B2 | Stabilized polyribonucleotide coding for an elastic fibrous protein | EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) | 2025-07-01 | — | — | US | claimed |
| EP-4561602-A1 | POLYNUCLEOTIDES ENCODING LINKED ANTIGENS AND USES THEREOF | Stemcell Technologies Canada Inc. (CA) | 2025-06-04 | — | — | EP | claimed |
| US-20250161488-A1 | THERAPEUTIC mRNA | THE UNIVERSITY OF MELBOURNE (AU) | 2025-05-22 | — | — | US | claimed |
| US-20250152737-A1 | LIPID NANOPARTICLES COMPRISING VENEZUELAN EQUINE ENCEPHALITIS (VEE) REPLICON AND USES THEREOF | STRAND THERAPEUTICS INC. (US) | 2025-05-15 | — | — | US | claimed |
| EP-4553084-A2 | USE OF IFN-LAMBDA MRNA FOR TREATING VIRAL INFECTIONS | Ethris GmbH (DE) | 2025-05-14 | — | — | EP | claimed |
| WO-2004046324-A2 | ALLELE-TARGETED RNA INTERFERENCE | UNIVERSITY OF MASSACHUSETTS (US) | 2004-06-03 | — | — | WO | claimed |
| US-20040059104-A1 | Nucleotide mimics and their prodrugs | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2004-03-25 | — | — | US | claimed |
| US-6635427-B2 | Kit for use in the amplification and quantification of preferential sequences | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2003-10-21 | — | — | US | claimed |
| EP-1307592-A2 | SINGLE-LABELED OLIGONUCLEOTIDE PROBES | University of Utah Research Foundation (US) | 2003-05-07 | — | — | EP | claimed |
| US-20030022177-A1 | Single-labeled oligonucleotide probes for homogeneous nucleic acid sequence analysis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-01-30 | — | — | US | claimed |
| WO-2002014555-A2 | SINGLE-LABELED OLIGONUCLEOTIDE PROBES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2002-02-21 | — | — | WO | claimed |
| WO-2000018780-A1 | NUCLEOSIDE MODIFICATIONS BY PALLADIUM CATALYZED METHODS | NEXSTAR PHARMACEUTICALS, INC. (US) | 2000-04-06 | — | — | WO | claimed |
| US-6020483-A | Nucleoside modifications by palladium catalyzed methods | NEXSTAR PHARMACEUTICALS, INC. (US) | 2000-02-01 | — | — | US | claimed |
| EP-0828750-A1 | PALLADIUM CATALYZED NUCLEOSIDE MODIFICATION METHODS USING NUCLEOPHILES AND CARBON MONOXIDE | NeXstar Pharmaceuticals, Inc. (US) | 1998-03-18 | — | — | EP | claimed |
| WO-1996038460-A1 | PALLADIUM CATALYZED NUCLEOSIDE MODIFICATION METHODS USING NUCLEOPHILES AND CARBON MONOXIDE | NEXSTAR PHARMACEUTICALS, INC. (US) | 1996-12-05 | — | — | WO | claimed |